• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Changes in tumor-antigen expression profile as human small-cell lung cancers progress

    2015-11-26 07:43:43LiShengGeNeilHoaNilsLambrechtMariaDacostaIyerYiOuyangAmirAbolhodaMartinJadus
    Cancer Biology & Medicine 2015年2期

    Li-Sheng Ge, Neil T. Hoa, Nils Lambrecht, Maria Dacosta-Iyer,3, Yi Ouyang,3, Amir Abolhoda, Martin R. Jadus,,3,5

    1Research Service,2Pathology and Laboratory Medicine Service, VA Long Beach Healthcare System, Long Beach, CA 90822, USA;3Pathology and Laboratory Medicine, University of California, Irvine, CA 92697, USA;4Surgical Health Care Group, Veterans Affairs Medical Center, Long Beach, CA 90822, USA;5Chao Family Comprehensive Cancer Center, UC, Irvine School of Medicine, University of California, Irvine, Orange, CA 92868, USA

    ORIGINAL ARTICLE

    Changes in tumor-antigen expression profile as human small-cell lung cancers progress

    Li-Sheng Ge1, Neil T. Hoa1, Nils Lambrecht2, Maria Dacosta-Iyer2,3, Yi Ouyang2,3, Amir Abolhoda4, Martin R. Jadus1,2,3,5

    1Research Service,2Pathology and Laboratory Medicine Service, VA Long Beach Healthcare System, Long Beach, CA 90822, USA;3Pathology and Laboratory Medicine, University of California, Irvine, CA 92697, USA;4Surgical Health Care Group, Veterans Affairs Medical Center, Long Beach, CA 90822, USA;5Chao Family Comprehensive Cancer Center, UC, Irvine School of Medicine, University of California, Irvine, Orange, CA 92868, USA

    Objective: Our group has previously observed that in patients with small-cell lung cancers (SCLCs), the expression of a tumor antigen, glioma big potassium (gBK) ion channel, is higher at the time of death than when the cancer is first treated by surgical resection. This study aimed to determine whether this dichotomy was common in other potential lung tumor antigens by examining the same patient samples using our more extensive profile analysis of tumor-antigen precursor protein (TAPP). We then tested the hypothesis that therapeutic intervention may inadvertently cause this increased gBK production.

    Methods: SCLC samples (eight surgical resections and three autopsy samples) and three control lungs were examined by quantitative real-time polymerase chain reaction for 42 potential TAPPs that represent potential T-cell-mediated immunological targets.

    Results: Twenty-two TAPP mRNAs displayed the same profile as gBK, i.e., more mRNAs were expressed at autopsy than in their surgical counterparts. B-cyclin and mouse double minute 2, human homolog of P53-binding protein were elevated in both autopsy and surgical specimens above the normal-lung controls. When HTB119 cells were incubated with doxorubicin, gBK was strongly induced, as confirmed by intracellular flow cytometry with a gBK-specific antibody.

    Conclusion: Our findings suggested that more immunological targets became available as the tumor responded to chemotherapy and proceeded toward its terminal stages.

    S mall-cell lung cancer (SCLC); glioma big potassium (gBK) ion channel; tumor antigens; immunoprevention; real-time polymerase chain reaction; T-lymphocytes

    Introduction

    Immunotherapy significantly affects the treatment of established human cancers. Dendritic cell (DC)-based immunotherapies use the patient’s own DCs that are fed with tumor extracts or antigenic peptides and are infused back into the patient. These antigen-loaded DCs then migrate to the lymph nodes and activate the host’s T-cells. These stimulated endogenousT-effector cells in turn seek out and kill the remaining tumor cells. In glioblastoma multiforme (GBM), this therapy has been proven effective against the “mesenchymal” subtype of GBM1. Positive responses have been observed for DC stimulated with the “Provenge” fusion molecule, i.e., the survival of patient with castrate resistant prostate cancer increases by 4 months2. Lung-cancer vaccines including those that use DC pulsed with antigenic peptides or killed whole cells are being developed and have been reviewed by Jadus et al.3. Antibodies toward so-called “check-point inhibitory” pathways such as programmed cell death-1, programmed cell death-1 ligand, and cytotoxic T-lymphocyte antigen-4 likewise affect patient survival in various cancer types, including non-small cell lung cancers (NSCLCs)4-6. These inhibitory molecules are expressed onregulatory T-cells (Treg) and tumor cells, effectively suppressing antitumor immune functions. In clinical trials using these checkpoint inhibitory antibodies, only about 25%-30% of cancer patients are successfully treated6, leaving plenty of room for improvement. Apart from understanding how tumors can inhibit the immune system, the identification of tumor antigens that can be used as potential vaccines is also important to prevent future tumor growth. By stimulating immune responses toward the cancer, more activated T-cells can be directed toward the tumor, which can eliminate tumor cells that are inaccessible to surgery or radiation. DCs loaded with tumor antigens can be easily merged with check-point inhibitory strategies to produce even better clinical outcomes.

    Previously, our group has worked with the glioma big potassium (gBK) ion channel7,8. This ion-channel variant has a 32 amino-acid insert found within the intracellular region of this BKα chain. This ion channel, initially cloned from human D54 glioma cells9(hence its initial descriptive name), is found within a wide variety of cancer types7-9but not within non-tumorous lymphocytes, fibroblasts, or human embryonic kidney cells. Ion channels including potassium, sodium, and chloride ion channels play important roles in tumor-cell migration10,11. BK channels are believed to play a role in glioma-cell migration10,11. Both gliomas and SCLCs are invasive cancers and could thus have similar migratory properties using these BK and gBK channels. BK channels, and probably gBK, are mechanosensitive ion channels, meaning that these channels are activated when the membrane is physically stretched12. Consequently, once internal K+cations are released, a positive feedback loop starts this infiltrative process and continues as the cell moves. X-ray irradiation of human T98G and U87 glioma cells immediately activates their BK channels and initially increases the mobility of these cells than their non-irradiated counterparts13. SCLCs favorably respond to radiation at the beginning14, but then the cancer returns at another anatomic site. Thus, BK ion channels may drive the invasion/metastatic processes of cancer cells as a consequence of therapeutic ionizing irradiation. When our group has investigated gBK with SCLC, we have discovered that SCLC autopsy specimens contain higher gBK mRNA levels than GBM autopsy material8. We have failed to see any up-regulation of the lung specific transcription factor Sox11 within the studied SCLC autopsy cases. Thus, this phenomenon is unlikely to be an artifact of the patient death process or simple RNA degradation.

    In the present work, we analyzed eight surgical samples from SCLC patients taken early in their treatment and found that these samples possessed minimal gBK mRNA. To determine whether this gBK dichotomy was an anomaly, we examined 42 other tumor antigens known to elicit T-cell-mediated responses. Twenty-two tumor-antigen precursor proteins (TAPPs) followed the same pattern as gBK. Two TAPPs, B-cyclin and mouse double minute 2, human homolog of P53-binding protein (MDM2), were elevated in both SCLC subsets studied. The remaining 18 TAPP mRNAs failed to show any significant expression within the SCLC specimens. We concluded earlier that this antigen expression profile may be an example of tumorantigen selection or tumor-cell clonal expansion. However the possibility exists that tumor antigen evolution may drive this antigen progression as a result of active therapeutic intervention. We used an HTB119 cell line that had not been previously exposed to any therapeutic intervention before this cell line was established. We showed an induction of gBK in response to doxorubicin exposure; thus, gBK may be a prototypical tumor antigen that can be stimulated by therapeutic intervention. This discovery can serve as a basis for the development of rational immunological interventions for antigens before the cancer expresses them. Therefore, immunoprevention can be considered to prevent the terminal stages of SCLC.

    Materials and methods

    Cell culture

    HTB119 (NCI-H69) and H1436 (NCI-H1436) SCLC cell lines were purchased from American Type Culture Collection (Manassas, VA, USA) and was cultured as described elsewhere8.

    Chemicals

    All chemotherapeutic agents were purchased from Sigma Chemical Corporation (St. Louis, MO, USA).

    Lung tumor tissue

    After an IRB expedited review was granted for this project, we collected either autopsy material or excess surgical material not needed for diagnostic purposes. We collected three autopsy samples from our SCLC cases, along with three lung samples taken from other autopsies, which did not have lung cancer. We purchased eight SCLC surgical cases from Oncomatrix (San Diego, CA, USA), who obtained their tissue from Eastern Europe where surgical resections of SCLC patients are still performed.

    Quantitative reverse-transcriptase real-time polymerase chain reaction (qRT-PCR)

    We used the same techniques and primers as those previouslydescribed15-17. We also designed primers that are reported to be expressed or over-expressed within lung cancers and to be able to elicit human immune responses18. These TAPPs included calgranulin forward: 5'-GCCACCACCATAAGCCAG-3'; reverse: 5'-ACCATGACTGTGGCCGTG-3'; CTL-recognized and on melanoma (CAMEL) forward: 5'-CGCTTCTGCGCAGGATGG-3'; reverse: 5'-CC ATG G G CG ACG AG A A AG-3'; c yclophi l in B for ward: 5'-CTCTTCCGGCCTCAGCTG-3'; reverse: 5'-AAGACGGACCCCGCGATG-3'; livin for ward: 5'-CGTG GTG G GTTCTTG AG C-3'; reverse: 5'-CACGGCACAAAGACGATG-3'; MDM2 f o r w a rd: 5'-ATG ATCCCCG AG G CCC AG-3'; reve r s e: 5'-CCG G G GT T T TCG CG CT TG-3'; parathyroid hormone-related protein (PTH-rP) forward: 5'-CCAAGGACATATTGCAGG-3'; reverse: 5'-GCAGTTTCATAGAGCAATGG-3'; trio guanine nucleotide exchange factor and regulates actin (TARA) forward: 5'-GCCATGACGCCCGATCTG-3'; reverse: 5'-AGGTGGT-GGTGAGCGAGG-3'; transthyretin (TTR) forward: 5'-GTCTGAGGCTGGCCCTAC-3'; reverse: 5'-ACGGCCACATTGATGGCAG-3'; X antigen family, member 1B (Xage-1B) forward: 5'-TTCGCCAGTGTGGGGAAC-3'; reverse: 5'-CCGCCGTGTCTCAGTAGC-3'. Samples were run in quadruplicate, and a reaction without cDNA established a baseline fluorescence level with 18S RNA. Fluorescent signal versus cycle number was plotted. Threshold cycle (Ct) was defined as the cycle number where a fluorescence signal could be reliably detected above background fluorescence. Each PCR run also included non-template controls containing all reagents except cDNA. After cycling, a melting curve was produced by slow denaturation of PCR end products to validate amplification specificity. The relative quantification of expression of any given gene was determined by the 2-ΔCtmethod19. mRNA expression was considered as a strongly positive signal when ΔCt= [6-14], as a moderately positive signal when ΔCt= [15-20], as a weak positive signal when ΔCt= [21-24], and as a negative signal when ΔCt>24 (the line displayed on the various panels). To statistically analyze the data, an arbitrary ΔCtscore of 25 was assigned to specimens in which a signal for the TAPP was not detected. Based on our previous qRT-PCR experience, a cutoff point of 24 was set for the ΔCtvalue that was biologically relevant. Cell lines having an mRNA score below this value routinely lacked protein for a given gene detected by antibodybased methods15. Data from each tumor sample was grouped according to tumor type and plotted. Statistical differences between normal-lung and SCLC samples were calculated using unpaired students t-tests, with P<0.05 considered significant.

    Immunofluorescent microscopy

    Three archival SCLC paraffin blocks collected from patients who died from their cancers with distant metastases were randomly chosen. Recut slides were first deparaffinized and treated with an antigen-retrieval reagent. These slides were immunostained using either non-immunized IgGs from different species, the mouse monoclonal anti-tyrosinase-related protein (Trp)-75 (also called Trp-1), goat anti-melanoma antigen (Mage)-1 polyclonal antibody [Lab Vision/Neomarkers (Fremont, CA, USA), or rabbit anti-telomerase reverse transcriptase (hTert) antibody (Santa Cruz. Biotech, Santa Cruz, CA, USA)]. The slides were washed and stained with the appropriate FITC-conjugated secondary antibodies (Vector Labs, Burlingame, CA, USA). Representative fluorescence images were captured using a Nikon Eclipse E600 fluorescence microscope with RTKE Spot Camera and Spot software.

    Intracellular flow cytometry

    Exponentially growing SCLC cells were fixed in Santa Cruz Biotechnology fixative, washed, and permeabilized using Santa Cruz Biotechnology. Afterwards, the cells were incubated with the primary antibody. The goat polyclonal antibody directed toward human gBK was made by GenScript Inc. (Piscataway, NJ, USA)7,8. A total of 10,000 cells were evaluated with a Bectin-Dickinson FACS Profile flow cytometer. The Kolmogorov-Smirnov statistics test was used to show the significance of differences in antibody staining profiles at P<0.05 level.

    Results

    Enhanced TAPP mRNA expression occurred only within SCLC autopsy specimens

    Our initial work dealt with cancer cells and the gBK ion channel7,8. We unexpectedly found that resected samples of SCLC (n=8) taken early during disease treatment possessed little gBK mRNA, as detected by qRT-PCR. However, at the time of death of three SCLC patients, gBK was highly expressed in these specimens. SCLC is derived from neuro-endocrine precursor cells (Kulchitsky cells)20and is an infiltrative tumor14like GBM, so gBK expression could indicate the invasive nature common to both cancers. We used our TAPP primer bank15,16to determine whether this dichotomy was a common or a novel phenomenon. We used some “universal” (e.g., B-cyclin, hTert, her2/neu, Mage, and MRP3) and “l(fā)ung-specific” (e.g., CAMEL, calgranulin, and Xage-1B)18antigens to address this issue.

    We collected three control lung samples that did not have cancer, and together with the previously used eight surgically resected SCLC specimens and three SCLC autopsy samples8, we subjected these RNA samples to qRT-PCR analysis. Results showed that for 22 TAPPs, the expression of these antigens was significantly elevated at the time of autopsy, and no or very low expression was observed when the SCLC surgical samples were compared with noncancerous lung tissue (Figure 1). These potential antigens included the following: antigen isolated from immunoselected melanoma-2, Aim2, antigen recognized by T-cells (ART)-4, calgranulin, carcinoembryonic antigen, cyclophilin B, polycomb group protein enhancer of zeste homolog 2 (EZH2), gBK, melanoma glycoprotein-100 (GP100; also called Pmel 17), livin, Mage-1, Mage-A4, Mage-A10, multidrugresistance protein-3 (MRP-3), preferentially expressed antigen in melanoma (PRAME), PTH-rP, squamous cell carcinoma ARTs (Sart)-1, Sart-3, the transcription factor Sox2, TARA, hTert, Trp-1, TTR, and Xage-1B. All these TAPP mRNAs were absent from SCLC surgical samples but present in autopsy samples.

    Two TAPPs were elevated in both surgical and SCLC autopsy samples

    Figure 1 Twenty-two TAPPs are expressed only within SCLC autopsy samples. Eight surgical resections of SCLC (square symbols), 3 SCLC autopsy samples (triangle symbols) and 3 control lungs samples (circle symbols) from autopsy patients who did not have any cancer were examined for these 22 TAPPs. Asterisks denote significant statistical differences (P<0.05) between the SCLC autopsy and normal lung autopsy values. The data on gBK was previously published in reference 8 and is shown here for comparison purposes with the other antigens.

    We found that two putative precursor antigens (B-cyclin and MDM2) were significantly elevated both in surgical samples andautopsy samples compared with normal-lung autopsy specimens (Figure 2). The surgical samples had an intermediate value, whereas the autopsy samples had higher amounts of mRNA. Thus, not all antigens displayed this all-or-none effect, suggesting that an intermediate level of TAPP can exist in SCLC surgical samples.

    Immunofluorescence microscopy confirmed that Tert, Mage-1, and Trp-1 TAPPs were present in SCLC autopsy specimens

    We confirmed the presence of three TAPPs at the protein level within SCLC samples by using antibodies directed against Tert, Mage-1, and Trp-1 proteins. Three archival SCLC histological samples with confirmed distant metastases collected from SCLC patients at the time of their deaths were stained with their respective antibodies, washed, and stained with an FITC-conjugated secondary antibody. All three SCLC samples showed tumors positively stained for these three TAPPs. The representative staining patterns shown in Figure 3 were those of samples collected from a metastatic lesion from the left ventricle. The first column shows the negative controls in which nonimmunized IgGs were applied with the appropriate secondaryantibody. The middle column shows a non-tumorous region of the left ventricle, and the right column shows the nest of SCLC cells. The top, middle, and bottom rows show Tert, Mage-1, and Trp-1 stainings, respectively. All SCLC cells stained strongly positive. The non-tumorous lung tissue was negative or weakly positive, as proven by their lowered green fluorescence; this internal control showed that the antibody did not stain every cell within the lung.

    Figure 2 Significant TAPP expression in both surgical and autopsy SCLC. The same RNA preparations used in Figure 1 were examined for B-cyclin and MDM2. In both experiments the mRNA levels displayed significant differences (P<0.05) between the normal lung mRNA when compared to the SCLC specimens.

    Figure 3 Immunofluorescence microscopy shows 3 TAPPs are present within SCLC specimens taken at autopsy. Three SCLC specimens were examined for expression of h-Tert, Mage-1, and Trp-1 by using antibodies directed towards these 3 TAPPs.

    Not all TAPP mRNA were found within autopsy samples

    A third TAPP mRNA profile failed to show any TAPP expression above control autopsy lung tissue levels (Figure 4). These 18 putative antigens included the following: ART-1, CAMEL, interleukin-13 receptor-α2, Mage-A3, New York esophageal-1 antigen, NY-Eso1, Sox11, and Trp-2. Twelve TAPPs [EphA2, Fos-related antigen-1 (also called Fosl1)], β1,6-N-acetylglucosaminyltransferase-V (GnT-V), her2/neu, high nuclear riboprotein-L (HNRPL), livin, Sart-2, survivin, Wolf-Hirschhorn syndrome candidate 2 protein (Whsc2), Wilms tumor antigen-1 (Wt-1), Ube2V, and chitinase 3-like 1 [cartilage glycoprotein-39; also called Tyr-Lys-Leu containing protein-40 (Ykl-40)]. They had overall trends toward being expressed but failed to show statistical significance perhaps because of the low numbers of SCLC autopsy samples that were tested.

    Doxorubicin can enhance gBK transcription in the HTB-119 SCLC cell line

    We used an HTB119 cell line established from an SCLC patient who had not been subjected to any therapy20,21. This cell line, which expressed minimal gBK protein, represented an initial SCLC case that was not selected because of any clinical intervention8. We collected these HTB119 cells and treated them for 2 weeks with various chemotherapeutic drugs that had been used to treat SCLC22. These cells were examined for gBK expression by qRT-PCR. Figure 5 shows the results of this experiment. Sub-lethal radiation (1,000 rad) and the drugs cisplatinum (50.0 μM), cyclophosphamide (2.5 μM), etoposide (50.0 μM), and doxorubicin (5.0 μM) were examined for theireffect on gBK mRNA levels. Cis-platinum, cyclophosphamide, and radiation failed to enhance gBK expression, whereas etoposide gave a slight elevation of gBK (1.5-fold), but this was not considered significantly different from the untreated control values (P=0.084). Doxorubicin displayed an elevated level of gBK transcription (115-fold). This mRNA level proved to be significant between the untreated control SCLC and those treated with doxorubicin (P=0.0001).

    Figure 4 TAPP expression does not show a differential pattern within SCLC tumors or normal lung tissue. The same preparations of RNA used in Figures 1 and 2 were also analyzed with these 18 different primer sets. The data from Sox11 was used in a previous paper8.

    Figure 5 gBK expression is induced in HTB119 by doxorubicin. HTB119 cells were cultured for two weeks under the various conditions. The cells were irradiated at Day 0 with 1,000 rad and then cultured. Cells were cultured with cis-platinum, cyclophosphamide, Etoposide or doxorubicin. The cells were lysed, the RNA was isolated and then analyzed for gBK or 18S RNA by qRT-PCR.

    We showed that elevated gBK mRNA expression was translated into protein by repeating the previous experiment and performing intracellular flow cytometry with the polyclonal antibody to gBK. Figure 6 shows that doxorubicin induced gBK expression in both HTB119 (top row) and another SCLC cell line, H1436 (bottom row). Etoposide significantly induced gBK protein expression in H1436 cells.

    Discussion

    Figure 6 gBK protein is induced with HTB119 and H1436 by doxorubicin. The exact same chemotherapeutic conditions from (Figure 5) were repeated using both HTB119 and H1436 SCLC cells. After 2 weeks of incubation, the cells were fixed, permeabilized and stained for gBK using the goat anti-human gBK antibody. After washing, they were stained with a mouse anti-goat IgG-FITC antibody. Subsequently these washed cells were analyzed by flow cytometry. Ten thousand cells were examined. The shaded area represents the fluorescence of the DMSO-treated controls stained for gBK, while the open area is the profile of the drug treated cells stained for gBK. CIS is Cis-platinum treated cells, CYC is cyclophosphamide treated cells, DOX is doxorubicin treated cells and ETO is Etoposide treated cell.

    The incidence of lung cancer is now declining in the USA as a result of active anti-smoking campaigns. However, in many developing countries, smoking and lung cancer rates are rising. SCLC accounts for about 15% of all diagnosed lung cancers, but very little clinical progress has been made in treating this form of lung cancer23. The 5-year survival of patients with this cancer is still dismal because of the cancer’s invasive/metastatic behavior. Promising clinical results occur when antibodies to“inhibitory checkpoints” are given to patients with varioussolid-organ cancers4-6, including NSCLCs. Understanding of the mechanisms by which host immunity can be augmented is important, but so is identifying antigens that can stimulate T-cell immune responses. Currently, the known antigens for SCLCs are few. Accordingly, this study was conducted to identify putative antigens with possible therapeutic use for SCLC patients. Once SCLC patients were vaccinated for the right antigens, these patients had more activated T-cells circulating in them, and the use of check-point inhibitory antibodies further enhanced the effectiveness of these T-cells.

    The gBK ion channel was initially recognized to be highly expressed only within SCLC autopsy samples, whereas very little gBK was detected in early-stage SCLC. What process led to our phenomenon still processes led to our phenomenon remains to be investigated. We expanded our prior work and studied a large panel of potential TAPPs to determine whether this dichotomy of expression was applicable to other tumor antigens. Indeed, we found that most TAPPs were elevated within SCLC autopsy samples. Many of these antigens were of a universal nature such as B-cyclin, Tert, and MRP-3, which allowed cancer cells to grow, replicate without chromosome shortening, and resist chemotherapy, respectively. Thus, the expression of these antigens did make biological sense. We confirmed that three TAPPs (Trp-1, Mage-1, and h-Tert) were elevated within three SCLC autopsy samples and were translated into protein as detected by antibody staining (Figure 3). Many of these up-regulated TAPPs are common in gliomas and other brain cancers15,16, such as Aim2, EZH2, GP100, Mage-1, MageA4, MageA10, Sart-1, -3, Trp-1, and Sox2 (Figure 1). SCLCs are derived from neuro-endocrine precursor cells, the so-called Kulchitsky cells20,21, which explains the shared antigen profile of SCLC with human gliomas. However, not every glioma specific TAPP was found to be elevated in these SCLC samples (Figure 3), e.g., IL-13Rα2. Thus, some differential specificity between SCLC and gliomas remained.

    Twelve TAPPs (EphA2, Fosl1, GnT-V, her2/neu, HNRPL, livin, Sart-2, survivin, Ube2V, Whsc2, Wt-1, and Ykl-40) had overall trends toward being different but failed to show statistical significance because of the low number of SCLC or control lung-autopsy samples tested to date, along with the higher standard error of means within these two groups. We began this study about 6 years ago and have collected only three SCLC autopsy cases to date. If this study was conducted about 20-30 years ago, more lung-cancer autopsies would have been easily collected. Nevertheless, we did achieve statistical significance for a number of TAPPs (Figures 1,2), but not for the 12 TAPPs that were trending in that direction (Figure 3). This research indicated that autopsies can still provide valuable insight into cancer biology and should still be encouraged.

    We initially believed that this progression of tumor antigens within SCLC may represent only the natural progression of this cancer. SCLC patients are almost always treated with either radiation or chemotherapeutic drugs. Previously, SCLCs have been treated with cis-platinum, cyclophosphamide, doxorubicin, or etoposide22. In the present study, we used the SCLC cell line HTB119 and showed that these cells displayed some gBK, but not as much as H1436 cells isolated after a patient received medical therapy. HTB119 cells were collected from a patient who did not receive any therapy23,24; hence, this tumor represented an early-stage SCLC. When doxorubicin was cultured with these HTB119 cells, gBK was reproducibly increased (Figures 5,6); when we cultured H1436 SCLC cells with doxorubicin, increased gBK expression occurred. Thus, other SCLC cells can respond in a similar manner, and further investigation on the mechanism of this induction is required. Interestingly, etoposide increased gBK in H1436 cells but not in HTB119 cells. Thus, some chemotherapeutics can drive antigenic expression in SCLC as they proceed toward their final outcome in some unknown manner. This knowledge provides a basis for vaccinating SCLC patients with tumor antigens and perhaps calter the final progression of this cancer through the concept of immunoprevention25.

    In support of this chemotherapeutic drug-induced gBK production, we observed that human glioma cells behaved the same way using the recently approved drug temozolomide (TMZ). TMZ is an alkylation and methylation drug that improves human GBM survival by 2.5 months26. We found that gBK mRNA and protein levels were significantly stimulated by TMZ in human glioma cell lines (TMZ induced the expression of gBK ion channel while inhibiting fascin-1 expression, i.e., possible synergistic enhancements for glioma immunotherapy, manuscript submitted). Thus, gBK induction may be a prototypical antigen mechanism showing that tumor antigen progression can be partly driven by chemotherapy in different cancer patients. This phenomenon of increased TAPP expression has been reported in melanoma cell lines when a BRAF inhibitor (vemurafenib) is administered. As a result of such treatment, GP100, Trp-1, Trp-2, and Mart-1 all increased both at the mRNA and protein levels27. Thus, some so-called“specific inhibitory” drugs like doxorubicin, TMZ, and vemurafenib still have off-label effects on the immune system.

    In summary, we showed that SCLC autopsy samples highly expressed 24 potential TAPPs that should theoretically elicit human T-cell responses. HTB119 cells that were developed from SCLC before applying any therapy induced gBK to respond to the chemotherapeutic drug doxorubicin. Therefore tumorantigen expression may be partly driven by chemotherapy and may provide immunological targets for vaccination protocols.

    Acknowledgements

    We thank Drs. Jonathan Zhang and Samar Azawi of the Radiation Therapy Department of VAMC-Long Beach for irradiating the cells that we used in Figure 4. Martin R. Jadus is supported by a VA Merit Review.

    Conflict of Interest Statement

    No potential conflicts of interest are disclosed.

    References

    1. Prins RM, Soto H, Konkankit V, Odesa SK, Eskin A, Yong WH, et al. Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Clin Cancer Res 2011;17:1603-1615.

    2. Gulley JL, Drake CG. Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research. Clin Cancer Res 2011;17:3884-3891.

    3. Jadus MR, Natividad J, Mai A, Ouyang Y, Lambrecht N, Szabo S, et al. Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention. Clin Dev Immunol 2012;2012:160724.

    4. Herbst RS, Soria JC, Kowanetz M, Fine GD, Hamid O, Gordon MS, et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature 2014;515:563-567.

    5. Phan GQ, Yang JC, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockades in patients with metastatic melanoma. Proc Natl Acad Sci U S A 2003;100:8372-8377.

    6. Hodi FS, O’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363:711-723.

    7. Ge L, Hoa NT, Cornforth AN, Bota DA, Mai A, Kim DI, et al. Glioma big potassium channel expression in human cancers and possible T cell epitopes for their immunotherapy. J Immunol 2012;189:2625-2634.

    8. Hoa NT, Zhang JG, Delgado CL, Myers MP, Callahan LL, Vandeusen G, et al. Human monocytes kill M-CSF-expressing glioma cells by BK channel activation. Lab Invest 2007;87:115-129.

    9. Liu X, Chang Y, Reinhart PH, Sontheimer H, Chang Y. Cloning and characterization of glioma BK, a novel BK channel isoform highly expressed in human glioma cells. J Neurosci 2002;22:1840-1849.

    10. Weaver AK, Liu X, Sontheimer H. Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells. J Neurosci Res 2004;78:224-234.

    11. Sontheimer H. An unexpected role for ion channels in brain tumor metastasis. Exp Biol Med (Maywood) 2008;233:779-791.

    12. Zhao H, Sokabe M. Tuning the mechanosensitivity of a BK channel by changing the linker length. Cell Res 2008;18:871-878.

    13. Steinle M, Palme D, Misovic M, Rudner J, Dittmann K, Lukowski R, et al. Ionizing radiation induces migration of glioblastoma cells by activating BK K(+) channels. Radiother Oncol 2011;101:122-126.

    14. Jackman DM, Johnson BE. Small-cell lung cancer. Lancet 2005;366:1385-1396.

    15. Zhang JG, Eguchi J, Kruse CA, Gomez GG, Fakhrai H, Schroter S, et al. Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics. Clin Cancer Res 2007;13:566-575.

    16. Zhang JG, Kruse CA, Driggers L, Hoa N, Wisoff J, Allen JC, et al. Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy. J Neurooncol 2008;88:65-76.

    17. Ge L, Cornforth AN, Hoa NT, Delgado C, Chiou SK, Zhou YH, et al. Differential glioma-associated tumor antigen expression profiles of human glioma cells grown in hypoxia. PLoS One 2012;7:e42661.

    18. Vigneron N, Stroobant V, Van den Eynde BJ, van der Bruggen P. Database of T cell-defined human tumor antigens: the 2013 update. Cancer Immun 2013;13:15.

    19. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.

    20. Forster BB, Müller NL, Miller RR, Nelems B, Evans KG. Neuroendocrine carcinomas of the lung: clinical, radiologic, and pathologic correlation. Radiology 1989;170:441-445.

    21. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. In: Travis WD, Brambilla E, Müller-Hermelink EK, Harris CC. editors. World health organization classification of tumours. Lyon: IARC Press; 2004:9-122.

    22. Roth BJ, Johnson DH, Einhorn LH, Schacter LP, Cherng NC, Cohen HJ, et al. Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. J Clin Oncol 1992:10:282-291.

    23. Bepler G, Jaques G, Neumann K, Aumüller G, Gropp C, Havemann K. Establishment, growth properties, and morphological characteristics of permanent human small cell lung cancer cell lines. J Cancer Res Clin Oncol 1987;113:31-40.

    24. Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, et al. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 1985;45:2913-2923.

    25. Forni G, Lollini PL, Musiani P, Colombo MP. Immunopreventionof cancer: is the time ripe? Cancer Res 2000;60:2571-2575.

    26. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10:459-466.

    27. Boni A, Cogdill AP, Dang P, Udayakumar D, Njauw CN, Sloss CM, et al. Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function. Cancer Res 2010;70:5213-5219.

    Cite this article as: Ge LS, Hoa NT, Lambrecht N, Dacosta-Iyer M, Ouyang Y, Abolhoda A, Jadus MR. Changes in tumor-antigen expression profile as human small-cell lung cancers progress. Cancer Biol Med 2015;12:96-105. doi: 10.7497/j.issn.2095-3941.2015.0027

    Correspondence to: Martin R. Jadus

    April 9, 2015; accepted May 13, 2015.

    E-mail: martin.jadus@va.gov

    Available at www.cancerbiomed.org

    Copyright ? 2015 by Cancer Biology & Medicine

    99久久精品国产亚洲精品| 久久99一区二区三区| 国产真人三级小视频在线观看| 在线 av 中文字幕| 黄色毛片三级朝国网站| 99久久精品国产亚洲精品| 久久香蕉激情| 夜夜爽天天搞| 人人妻人人澡人人看| 国产伦理片在线播放av一区| 99国产综合亚洲精品| 免费观看a级毛片全部| 熟女少妇亚洲综合色aaa.| 王馨瑶露胸无遮挡在线观看| 国产在线一区二区三区精| www.999成人在线观看| 最近最新中文字幕大全免费视频| 国产单亲对白刺激| 日韩免费高清中文字幕av| 久久久久久人人人人人| 亚洲精品粉嫩美女一区| 成人黄色视频免费在线看| 久久午夜综合久久蜜桃| 少妇 在线观看| 狠狠婷婷综合久久久久久88av| 超碰成人久久| 两性夫妻黄色片| 后天国语完整版免费观看| 多毛熟女@视频| 老司机深夜福利视频在线观看| 自线自在国产av| 国产欧美日韩精品亚洲av| 99riav亚洲国产免费| 精品午夜福利视频在线观看一区 | 亚洲精品中文字幕在线视频| 美女高潮喷水抽搐中文字幕| 制服诱惑二区| 啦啦啦中文免费视频观看日本| 亚洲精品在线美女| 黄片小视频在线播放| 电影成人av| 精品午夜福利视频在线观看一区 | 欧美日韩中文字幕国产精品一区二区三区 | 最近最新免费中文字幕在线| 欧美一级毛片孕妇| 亚洲一区中文字幕在线| 国产又爽黄色视频| 99国产精品一区二区蜜桃av | 色老头精品视频在线观看| 国产精品麻豆人妻色哟哟久久| 国产精品自产拍在线观看55亚洲 | 精品国产国语对白av| 天天躁夜夜躁狠狠躁躁| 久久精品人人爽人人爽视色| 国产成人免费观看mmmm| 亚洲va日本ⅴa欧美va伊人久久| 免费看a级黄色片| 欧美人与性动交α欧美软件| 日韩视频在线欧美| 男女边摸边吃奶| 在线播放国产精品三级| 久久久久久免费高清国产稀缺| 蜜桃在线观看..| 久久精品91无色码中文字幕| 久久人人爽av亚洲精品天堂| 国产欧美日韩一区二区三区在线| 久久中文字幕人妻熟女| 91麻豆av在线| 水蜜桃什么品种好| 精品乱码久久久久久99久播| av福利片在线| 女人爽到高潮嗷嗷叫在线视频| 久久精品国产a三级三级三级| 91成年电影在线观看| 黄色片一级片一级黄色片| 黄色毛片三级朝国网站| 久久久国产欧美日韩av| 夜夜爽天天搞| 国产日韩一区二区三区精品不卡| 国产欧美日韩一区二区三区在线| 肉色欧美久久久久久久蜜桃| 欧美中文综合在线视频| 婷婷成人精品国产| 国产免费现黄频在线看| av网站在线播放免费| 757午夜福利合集在线观看| 巨乳人妻的诱惑在线观看| 亚洲一码二码三码区别大吗| 制服人妻中文乱码| 亚洲国产成人一精品久久久| 久久中文字幕一级| 国产成人啪精品午夜网站| 又紧又爽又黄一区二区| 久久久久精品人妻al黑| 日韩一卡2卡3卡4卡2021年| 午夜福利视频精品| 欧美精品高潮呻吟av久久| 男女下面插进去视频免费观看| 亚洲avbb在线观看| 亚洲五月色婷婷综合| 国产高清激情床上av| 电影成人av| 久久ye,这里只有精品| 黄网站色视频无遮挡免费观看| 国产精品免费一区二区三区在线 | 桃花免费在线播放| 曰老女人黄片| 久久av网站| 久久九九热精品免费| 亚洲情色 制服丝袜| 亚洲国产成人一精品久久久| 亚洲国产精品一区二区三区在线| 欧美精品av麻豆av| 热re99久久精品国产66热6| 欧美激情极品国产一区二区三区| 一本色道久久久久久精品综合| av不卡在线播放| 亚洲精品久久成人aⅴ小说| 18在线观看网站| 一级毛片女人18水好多| 丁香六月天网| 最新的欧美精品一区二区| 国产在线精品亚洲第一网站| 亚洲精品在线观看二区| 国产精品久久久久久人妻精品电影 | 国产在线一区二区三区精| 性色av乱码一区二区三区2| 国产亚洲欧美精品永久| 超碰97精品在线观看| 国产午夜精品久久久久久| 日本wwww免费看| 国产成+人综合+亚洲专区| 午夜福利欧美成人| 黄片大片在线免费观看| 9191精品国产免费久久| kizo精华| 色婷婷av一区二区三区视频| 黄色成人免费大全| 国产在线免费精品| 少妇的丰满在线观看| 曰老女人黄片| 女人久久www免费人成看片| 极品人妻少妇av视频| 亚洲自偷自拍图片 自拍| 在线观看免费视频网站a站| 这个男人来自地球电影免费观看| 精品国产国语对白av| 男女无遮挡免费网站观看| 国产黄色免费在线视频| 大片免费播放器 马上看| 欧美av亚洲av综合av国产av| 啪啪无遮挡十八禁网站| 日日爽夜夜爽网站| 国产主播在线观看一区二区| 免费在线观看黄色视频的| 国产免费av片在线观看野外av| 欧美亚洲 丝袜 人妻 在线| 91老司机精品| 欧美精品高潮呻吟av久久| 久久久久国内视频| 午夜日韩欧美国产| 欧美精品高潮呻吟av久久| 18在线观看网站| 真人做人爱边吃奶动态| 亚洲精品久久成人aⅴ小说| 久久午夜亚洲精品久久| 丰满少妇做爰视频| 深夜精品福利| 日韩有码中文字幕| 成年版毛片免费区| 精品少妇黑人巨大在线播放| av又黄又爽大尺度在线免费看| 黄色成人免费大全| 黄色视频不卡| 法律面前人人平等表现在哪些方面| 黄网站色视频无遮挡免费观看| 国产精品一区二区在线观看99| 亚洲伊人久久精品综合| av免费在线观看网站| 久久亚洲精品不卡| 国产极品粉嫩免费观看在线| 777久久人妻少妇嫩草av网站| 国产欧美日韩精品亚洲av| 国产精品亚洲av一区麻豆| 欧美精品亚洲一区二区| 90打野战视频偷拍视频| 午夜成年电影在线免费观看| 亚洲av成人不卡在线观看播放网| 99riav亚洲国产免费| 亚洲av成人一区二区三| 亚洲成人国产一区在线观看| 亚洲精品乱久久久久久| 成人av一区二区三区在线看| 亚洲黑人精品在线| 咕卡用的链子| 99re6热这里在线精品视频| 久久久久久亚洲精品国产蜜桃av| 超碰97精品在线观看| 精品国产乱码久久久久久男人| 一级毛片电影观看| 在线亚洲精品国产二区图片欧美| 视频在线观看一区二区三区| 亚洲va日本ⅴa欧美va伊人久久| 高清视频免费观看一区二区| 欧美日韩亚洲国产一区二区在线观看 | 欧美性长视频在线观看| 精品人妻在线不人妻| 别揉我奶头~嗯~啊~动态视频| 夜夜骑夜夜射夜夜干| 欧美黄色片欧美黄色片| 成年人黄色毛片网站| 精品第一国产精品| 丝瓜视频免费看黄片| 高清黄色对白视频在线免费看| av天堂久久9| 久久精品国产a三级三级三级| 中国美女看黄片| 成人精品一区二区免费| 中文字幕人妻丝袜一区二区| www.精华液| 在线亚洲精品国产二区图片欧美| 免费人妻精品一区二区三区视频| 国产老妇伦熟女老妇高清| 欧美日本中文国产一区发布| 男女高潮啪啪啪动态图| 美女视频免费永久观看网站| 18在线观看网站| 久久 成人 亚洲| 精品视频人人做人人爽| 国产精品亚洲av一区麻豆| 亚洲成人免费电影在线观看| 国产男女超爽视频在线观看| 黄色怎么调成土黄色| 国产一区有黄有色的免费视频| 成人手机av| 国产免费视频播放在线视频| 久久精品aⅴ一区二区三区四区| 视频区图区小说| 亚洲精品一卡2卡三卡4卡5卡| 老司机影院毛片| 国产高清国产精品国产三级| 国产亚洲精品第一综合不卡| 别揉我奶头~嗯~啊~动态视频| 亚洲色图av天堂| www.999成人在线观看| 久久久国产一区二区| 伊人久久大香线蕉亚洲五| 久久久久久久久久久久大奶| 在线十欧美十亚洲十日本专区| 日本黄色日本黄色录像| 国产人伦9x9x在线观看| 亚洲精品久久成人aⅴ小说| 久久久精品国产亚洲av高清涩受| 免费在线观看影片大全网站| 久久久久国内视频| 水蜜桃什么品种好| 男女下面插进去视频免费观看| 男男h啪啪无遮挡| 在线永久观看黄色视频| 可以免费在线观看a视频的电影网站| 欧美日韩黄片免| 国产精品久久久久久人妻精品电影 | 1024香蕉在线观看| 大片电影免费在线观看免费| www.自偷自拍.com| 制服诱惑二区| 动漫黄色视频在线观看| 日韩人妻精品一区2区三区| 99久久99久久久精品蜜桃| 高清视频免费观看一区二区| 男女高潮啪啪啪动态图| 精品一品国产午夜福利视频| 夜夜夜夜夜久久久久| 欧美 日韩 精品 国产| 1024视频免费在线观看| 午夜激情av网站| 国产精品自产拍在线观看55亚洲 | 久久久久久人人人人人| 欧美日韩视频精品一区| 午夜两性在线视频| 电影成人av| 高清欧美精品videossex| 十八禁网站免费在线| 精品午夜福利视频在线观看一区 | 国产熟女午夜一区二区三区| 老司机在亚洲福利影院| 亚洲一码二码三码区别大吗| 亚洲va日本ⅴa欧美va伊人久久| 亚洲av日韩精品久久久久久密| 久久ye,这里只有精品| 久久国产精品男人的天堂亚洲| 女警被强在线播放| 国产一区二区三区视频了| 视频在线观看一区二区三区| 亚洲欧美精品综合一区二区三区| 最近最新中文字幕大全免费视频| 两性午夜刺激爽爽歪歪视频在线观看 | 亚洲三区欧美一区| 亚洲av国产av综合av卡| 午夜激情av网站| 天堂中文最新版在线下载| 国产成人免费无遮挡视频| 亚洲精品一二三| 国产精品亚洲av一区麻豆| 成人国产一区最新在线观看| 国产精品美女特级片免费视频播放器 | 一夜夜www| 99久久99久久久精品蜜桃| 久久久水蜜桃国产精品网| 中亚洲国语对白在线视频| 十八禁人妻一区二区| 女性被躁到高潮视频| 日韩视频一区二区在线观看| 午夜91福利影院| 欧美日本中文国产一区发布| 亚洲精品久久午夜乱码| 国产91精品成人一区二区三区 | 人人妻人人爽人人添夜夜欢视频| 国产成人啪精品午夜网站| 波多野结衣av一区二区av| 国产国语露脸激情在线看| 精品一区二区三区视频在线观看免费 | 动漫黄色视频在线观看| 久久久久国内视频| 黄色视频在线播放观看不卡| 电影成人av| 大片免费播放器 马上看| 91精品三级在线观看| 制服人妻中文乱码| 久热这里只有精品99| 午夜激情久久久久久久| 久久久国产欧美日韩av| 亚洲成国产人片在线观看| 韩国精品一区二区三区| 菩萨蛮人人尽说江南好唐韦庄| 纯流量卡能插随身wifi吗| 成人黄色视频免费在线看| 国产精品1区2区在线观看. | 日韩大码丰满熟妇| 日韩一区二区三区影片| 国产色视频综合| 侵犯人妻中文字幕一二三四区| 18禁美女被吸乳视频| 精品卡一卡二卡四卡免费| 在线天堂中文资源库| 成人18禁高潮啪啪吃奶动态图| 日韩欧美一区二区三区在线观看 | 丁香六月欧美| 成人免费观看视频高清| 午夜福利视频精品| 国产男女超爽视频在线观看| 国产在视频线精品| 久久精品国产亚洲av高清一级| 美国免费a级毛片| 亚洲人成77777在线视频| 国产精品电影一区二区三区 | 亚洲一卡2卡3卡4卡5卡精品中文| 黄色 视频免费看| 国产精品偷伦视频观看了| 麻豆成人av在线观看| 国产精品久久久久久人妻精品电影 | 女人久久www免费人成看片| 久久青草综合色| 亚洲成av片中文字幕在线观看| 久久ye,这里只有精品| 另类亚洲欧美激情| 久久ye,这里只有精品| 亚洲视频免费观看视频| 91大片在线观看| 久久毛片免费看一区二区三区| 亚洲国产欧美在线一区| 国产又色又爽无遮挡免费看| 久久久久国产一级毛片高清牌| 亚洲成人免费av在线播放| 精品久久久久久电影网| 乱人伦中国视频| 在线观看免费午夜福利视频| 狠狠精品人妻久久久久久综合| 国产熟女午夜一区二区三区| 悠悠久久av| 精品熟女少妇八av免费久了| 三上悠亚av全集在线观看| 国产极品粉嫩免费观看在线| 亚洲全国av大片| 欧美日韩福利视频一区二区| 国产成人欧美| 麻豆国产av国片精品| 蜜桃国产av成人99| 亚洲人成电影观看| 久热爱精品视频在线9| 久久久久久久久久久久大奶| 国产精品98久久久久久宅男小说| 一级,二级,三级黄色视频| 侵犯人妻中文字幕一二三四区| 丝袜人妻中文字幕| 日韩中文字幕欧美一区二区| a在线观看视频网站| 动漫黄色视频在线观看| 国产av又大| 婷婷成人精品国产| 亚洲人成电影免费在线| 欧美+亚洲+日韩+国产| 视频区图区小说| 99国产极品粉嫩在线观看| 亚洲免费av在线视频| 精品亚洲成国产av| 成年女人毛片免费观看观看9 | 十八禁网站免费在线| 国精品久久久久久国模美| videosex国产| 丰满少妇做爰视频| 免费观看av网站的网址| 在线十欧美十亚洲十日本专区| 99国产精品一区二区蜜桃av | kizo精华| 黄色a级毛片大全视频| 成年人免费黄色播放视频| 精品少妇内射三级| 久久国产精品大桥未久av| 日韩免费高清中文字幕av| 满18在线观看网站| 9热在线视频观看99| 亚洲精华国产精华精| 国产视频一区二区在线看| 久久午夜亚洲精品久久| 中文字幕制服av| 日本撒尿小便嘘嘘汇集6| videos熟女内射| 欧美成人免费av一区二区三区 | 91国产中文字幕| 另类精品久久| 极品人妻少妇av视频| 国产一区有黄有色的免费视频| 免费久久久久久久精品成人欧美视频| 久久毛片免费看一区二区三区| 黄片播放在线免费| 一个人免费在线观看的高清视频| 757午夜福利合集在线观看| 一级,二级,三级黄色视频| 精品一区二区三区视频在线观看免费 | videos熟女内射| 一级片'在线观看视频| 热99久久久久精品小说推荐| 亚洲色图综合在线观看| 亚洲性夜色夜夜综合| 老司机深夜福利视频在线观看| 亚洲黑人精品在线| 亚洲精品国产区一区二| 两人在一起打扑克的视频| 亚洲欧美色中文字幕在线| 夫妻午夜视频| 捣出白浆h1v1| 日韩免费高清中文字幕av| 欧美精品一区二区大全| 丰满饥渴人妻一区二区三| 国产精品美女特级片免费视频播放器 | 久久久国产成人免费| 自线自在国产av| 日韩中文字幕视频在线看片| 国产一卡二卡三卡精品| 99国产精品99久久久久| 亚洲av日韩在线播放| 国产日韩欧美视频二区| 人人妻人人澡人人看| 在线观看一区二区三区激情| 国产成人啪精品午夜网站| 另类亚洲欧美激情| 中文字幕av电影在线播放| 91av网站免费观看| 国产视频一区二区在线看| 亚洲人成电影免费在线| 国产日韩欧美在线精品| 两个人看的免费小视频| 视频区欧美日本亚洲| 91九色精品人成在线观看| 最近最新免费中文字幕在线| 亚洲国产欧美日韩在线播放| 一本色道久久久久久精品综合| 午夜福利一区二区在线看| 免费av中文字幕在线| 男女床上黄色一级片免费看| 亚洲av成人一区二区三| 国产精品 国内视频| 国产成人欧美| 成年女人毛片免费观看观看9 | 亚洲精品粉嫩美女一区| 热99国产精品久久久久久7| 十八禁人妻一区二区| 亚洲全国av大片| 亚洲综合色网址| 一进一出好大好爽视频| 久久青草综合色| 91av网站免费观看| 亚洲三区欧美一区| 色婷婷av一区二区三区视频| 另类亚洲欧美激情| 精品少妇内射三级| 电影成人av| 久久久久久人人人人人| 人妻久久中文字幕网| 男女床上黄色一级片免费看| 午夜福利影视在线免费观看| 亚洲精品自拍成人| 中文字幕制服av| 色综合欧美亚洲国产小说| 欧美激情 高清一区二区三区| 午夜日韩欧美国产| 男女边摸边吃奶| 91字幕亚洲| 亚洲国产中文字幕在线视频| 国产欧美日韩精品亚洲av| 99久久99久久久精品蜜桃| 老鸭窝网址在线观看| 亚洲精品中文字幕在线视频| 老司机午夜福利在线观看视频 | 夫妻午夜视频| 黄色视频不卡| 曰老女人黄片| 国产极品粉嫩免费观看在线| 午夜福利乱码中文字幕| 国产1区2区3区精品| 久久精品国产亚洲av高清一级| 另类精品久久| 大码成人一级视频| 久久久久精品人妻al黑| 五月天丁香电影| 99riav亚洲国产免费| 精品人妻1区二区| 亚洲精品国产色婷婷电影| 女人久久www免费人成看片| 欧美日韩av久久| 日本一区二区免费在线视频| 国产不卡一卡二| 亚洲精品av麻豆狂野| 18禁美女被吸乳视频| 超碰97精品在线观看| 可以免费在线观看a视频的电影网站| 欧美黄色片欧美黄色片| 国产精品久久久久成人av| 欧美成狂野欧美在线观看| 亚洲国产毛片av蜜桃av| 精品少妇久久久久久888优播| 亚洲av第一区精品v没综合| 激情视频va一区二区三区| e午夜精品久久久久久久| 热99久久久久精品小说推荐| 91九色精品人成在线观看| 黄片大片在线免费观看| 日韩成人在线观看一区二区三区| 色视频在线一区二区三区| 日本a在线网址| 国产无遮挡羞羞视频在线观看| e午夜精品久久久久久久| 免费在线观看完整版高清| 又黄又粗又硬又大视频| 久久性视频一级片| 搡老岳熟女国产| 高潮久久久久久久久久久不卡| 肉色欧美久久久久久久蜜桃| 亚洲精品中文字幕在线视频| 2018国产大陆天天弄谢| 久久久国产精品麻豆| 亚洲精品成人av观看孕妇| 国产麻豆69| a级片在线免费高清观看视频| 黑人操中国人逼视频| 欧美日韩成人在线一区二区| 欧美av亚洲av综合av国产av| 久久青草综合色| 欧美精品人与动牲交sv欧美| 乱人伦中国视频| 久久人妻av系列| 精品国产乱码久久久久久男人| 国产精品久久久久久精品古装| 亚洲综合色网址| 日韩熟女老妇一区二区性免费视频| 久久国产精品影院| 成人国产av品久久久| 国产亚洲午夜精品一区二区久久| 国产成人精品在线电影| 一边摸一边做爽爽视频免费| 中文字幕色久视频| 国产精品九九99| 亚洲欧美日韩另类电影网站| 亚洲成国产人片在线观看| 国产在线视频一区二区| 九色亚洲精品在线播放| 女人精品久久久久毛片| 老汉色av国产亚洲站长工具| 国产精品98久久久久久宅男小说| e午夜精品久久久久久久| www.999成人在线观看| 老司机在亚洲福利影院| av片东京热男人的天堂| 深夜精品福利| 精品福利观看| 最新在线观看一区二区三区| 亚洲精品美女久久av网站| 一级a爱视频在线免费观看| 操美女的视频在线观看| 亚洲精品美女久久久久99蜜臀| 一边摸一边抽搐一进一出视频| 亚洲国产av新网站| 高清视频免费观看一区二区| 亚洲午夜精品一区,二区,三区| 老司机午夜十八禁免费视频| 日韩欧美三级三区| 一边摸一边抽搐一进一出视频| aaaaa片日本免费| 国产欧美日韩精品亚洲av| 一级a爱视频在线免费观看| 首页视频小说图片口味搜索| 国产三级黄色录像| 黄网站色视频无遮挡免费观看| 国产亚洲欧美精品永久|